吸入麻醉市场:各产品，各用途，各终端用户，各地区- 规模，占有率，展望，机会分析，2023年～2030年

市场动态:

慢性病患病率的增加、老年人口的增加、急诊病例和手术数量的增加、吸入麻醉需求的增加以及COVID-19（大流行）的爆发将对预测期内的全球吸入麻醉市场做出贡献。这是预计增加市场增长的主要因素。

本调查的主要特征

• 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球吸入麻醉市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球吸入麻醉市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球吸入麻醉市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球吸入麻醉市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查的目的与前提条件

• 调查的目的
• 前提条件
• 简称

第2章 市场展望

• 报告概要
  • 市场定义和范围
• 摘要整理
  • 市场概述:各产品
  • 市场概述:各用途
  • 市场概述:各终端用户
  • 市场概述:各地区
• 连贯·机遇·地图(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 机会
• 影响分析
• 主要的焦点
• 法规方案
• 产品销售/核准
• PEST分析
• PORTER的分析
• 合併·收购情势

第4章 吸入麻醉的全球市场-冠状病毒(COVID-19)大流行病影响

• COVID-19流行病学
• 供给面和需求面的分析
• 经济影响

第5章 吸入麻醉的全球市场，各产品，2017-2030年

• 七氟醚
• 地氟烷
• 异氟烷
• 一氧化二氮

第6章 吸入麻醉的全球市场，各用途，2017年～2030年

• 引进
• 维修

第7章 吸入麻醉的全球市场:各终端用户，2017年～2030年

• 医院
• 门诊病人手术中心

第8章 吸入麻醉的全球市场，各地区，2017年～2030年

• 北美
• 欧洲
• 亚太地区
• 南美
• 中东·非洲地区

第9章 竞争情形

• Abbvie Inc.
• Novartis AG
• Piramal Enterprises Ltd.
• Hikma Pharmaceuticals Plc
• Fresenius SE & CO. KGaA
• Baxter International Inc.
• Troikaa Pharmaceuticals, Ltd.
• Halocarbon Products Corporation
• Jiangsu Hengrui Medicine Co., Ltd.
• Lunan Pharmaceutical Group Co. Ltd.

第10章 章节

• 关于调查手法
• 关于出版社

Inhalation anesthetics (such as nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane; most commonly used agents in practice today) are used for induction and maintenance of general anesthesia in the operating room. Inhaled anesthetics are preferred for maintenance of anesthesia because they allow a more precise control of the anesthetic state and do so at low cost.

Market Dynamics:

Increasing prevalence of chronic disease, growing geriatric (aging) population, increasing number of emergency cases and surgical interventions, increase in demand for inhalation anesthesia, and outbreak of COVID-19 (pandemic) are major factors expected to augment the growth of the global inhalation anesthesia market during the forecast period.

For instance, in August 2022, Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announced the First to Market Generic U.S. launch of the Zinc Sulfate Injection. This product is U.S. Food and Drug Administration approved with Competitive Generic Therapy (CGT) designation; an approval pathway intended to enhance market competition for sole source drugs. The injection is available in 30mg/10mL (3mg/mL) and 25mg/5mL (5mg/mL).

Key features of the study:

• This report provides in-depth analysis of the global inhalation anesthesia market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2020 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global inhalation anesthesia market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbvie Inc., Novartis AG, Piramal Enterprises Ltd., Hikma Pharmaceuticals Plc, Fresenius SE & CO. KGaA, Halocarbon Products Corporation, Baxter International Inc., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global inhalation anesthesia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation anesthesia market.

Detailed Segmentation:

• Global Inhalation Anesthesia Market, By Product:
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
• Global Inhalation Anesthesia Market, By Application:
  • Induction
  • Maintenance
• Global Inhalation Anesthesia Market, By End User:
  • Hospitals
  • Ambulatory Surgical Centers
• Global Inhalation Anesthesia Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Abbvie Inc.
  • Novartis AG
  • Piramal Enterprises Ltd.
  • Hikma Pharmaceuticals Plc
  • Fresenius SE & CO. KgaA
  • Baxter International Inc.
  • Troikaa Pharmaceuticals, Ltd.
  • Halocarbon Products Corporation
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Lunan Pharmaceutical Group Co. Ltd.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • High burden of chronic disease and growing geriatric population
  • Side-effects and rise in demand or adoption of generic drugs
  • Increasing demand or use of novel inhalation anesthetic drugs
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Inhalation Anesthesia Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Inhalation Anesthesia Market, By Product, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Sevoflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Desflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Isoflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Nitrous Oxide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Inhalation Anesthesia Market, By Application, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Induction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Maintenance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Inhalation Anesthesia Market, By End User, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

8. Global Inhalation Anesthesia Market, By Geography, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

9. Competitive Landscape

• Abbvie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Piramal Enterprises Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hikma Pharmaceuticals Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius SE & CO. KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Troikaa Pharmaceuticals, Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Halocarbon Products Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jiangsu Hengrui Medicine Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lunan Pharmaceutical Group Co. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us